Business
AngioDynamics to Present at Two Investor Conferences in March
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,
About this update from Angiodynamics, Inc.
[{"type":"text","content":" LATHAM, N.Y.--(BUSINESS WIRE)--\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March:\n\n\nConference: Barclays Global Healthcare Conference\nLocation: Miami Beach, FL\nDate: Wednesday, March 11, 2020\nPresentation: 4:50 p.m. ET\nSpeakers: Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President & Chief Financial Officer\n\n\nConference: Oppenheimer Healthcare Conference\nLocation: New York, NY\nDate: Wednesday, March 18, 2020\nPresentation: 10:20 a.m. ET\nSpeaker: Stephen Trowbridge, Executive Vice President & Chief Financial Officer\n\n\nA live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.\n\n\nAbout AngioDynamics, Inc.\n\n\nAngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200227005878/en/\n\nInvestors:\nAngioDynamics, Inc.\nStephen Trowbridge, Executive Vice President & CFO\n(518) 795-1408\n\nSource: AngioDynamics, Inc.","length":3440,"tagName":"div"}]